ArticleCancer chemotherapy and pharmacology2012

An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.

Hajime Asahina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.